Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
Giuseppe Tarantini, Marco Mojoli, Ferdinando Varbella, Roberto Caporale, Stefano Rigattieri, Giuseppe Andò, Plinio Cirillo, Simona Pierini, Andrea Santarelli, Paolo Sganzerla, Luisa Cacciavillani, Luciano Babuin, Nicoletta De Cesare, Ugo Limbruno, Alberto Massoni, Andrea Rognoni, Daniela Pavan, Flavia Belloni, Carlo Cernetti, Luca Favero, Francesco Saia, Luca Nai Fovino, Giulia Masiero, Loris Roncon, Valeria Gasparetto, Marco Ferlini, Federico Ronco, Roberta Rossini, Paolo Canova, Daniela Trabattoni, Alessandra Russo, Vincenzo Guiducci, Carlo Penzo, Fabio Tarantino, Ciro Mauro, Elena Corrada, Giovanni Esposito, Alfredo Marchese, Sérgio Berti, Matteo Martinato, Danila Azzolina, Darío Gregori, Dominick J. Angiolillo, Giuseppe Musumeci
Topics & Concepts
MedicineTicagrelorPrasugrelPercutaneous coronary interventionAcute coronary syndromeMyocardial infarctionInternal medicineClinical endpointRandomized controlled trialP2Y12CardiologyPopulationEnvironmental healthAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchAtrial Fibrillation Management and Outcomes